Published in AIDS Weekly, October 28th, 1996
The technique, which has so far been tested only in cultured human cells, relies on gene therapy with a non-working virus protein to "vaccinate" HIV infection-prone cells, according to a report in the October 15, 1996, issue of the Proceedings of the National Academy of Science (Proceedings of the National Academy of Sciences 1996;93:11477-11481).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.